Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray

PHASE3CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

ciclesonide

74 mcg ciclesonide nasal aerosol once daily

DRUG

mometasone

200 mcg mometasone aqueous nasal spray once daily

Trial Locations (15)

55402

Clinical Research Institute Inc., Minneappolis

63141

The Clinical Research Center, L.L.C., St Louis

68123

The Asthma and Allergy Center, PC, Bellevue

75231

Pharmacuetical Research & Consulting, Inc., Dallas

78229

Sylvania Research, San Antonio

79903

Western Sky Medical Research, El Paso

80907

Asthma & Allergy Associates, P.C., Colorado Springs

92120

Allergy Associates Medical Group, Inc., San Diego

92123

Allergy & Asthma Medical Group & Research Center, A.P.C., San Diego

92647

Asthma and Allergy Specialists Medical Group, Huntington Beach

92691

Southern California Research, Mission Veijo

97202

Allergy Associates Research Center, Portland

97504

Clinical Research Institute of Southern Oregon, PC, Medford

02747

Northeast Medical Research Associates, Inc., North Dartmouth

08558

Princeton Center for Clinical Research, Skillman

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT01401465 - Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray | Biotech Hunter | Biotech Hunter